Miromatrix Medical Inc. (NASDAQ:MIRO – Get Rating) rose 0.5% on Tuesday . The stock traded as high as $2.82 and last traded at $2.82. Approximately 1,637 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 32,099 shares. The stock had previously closed at $2.80.
Miromatrix Medical Trading Up 0.5 %
The company has a debt-to-equity ratio of 0.07, a current ratio of 18.54 and a quick ratio of 18.54. The company’s 50-day moving average is $3.38 and its two-hundred day moving average is $3.57.
Miromatrix Medical (NASDAQ:MIRO – Get Rating) last announced its quarterly earnings results on Monday, May 16th. The company reported ($0.35) earnings per share for the quarter. Miromatrix Medical had a negative net margin of 62,805.01% and a negative return on equity of 38.24%. The business had revenue of $0.01 million during the quarter.
Hedge Funds Weigh In On Miromatrix Medical
Hedge funds have recently modified their holdings of the company. Sweet Financial Partners LLC bought a new position in shares of Miromatrix Medical during the 4th quarter worth approximately $47,000. Ulland Investment Advisors LLC bought a new position in shares of Miromatrix Medical during the 1st quarter worth approximately $48,000. Legacy Wealth Asset Management LLC bought a new position in shares of Miromatrix Medical during the 2nd quarter worth approximately $54,000. State Street Corp bought a new position in shares of Miromatrix Medical during the 1st quarter worth approximately $93,000. Finally, Commonwealth Equity Services LLC bought a new position in shares of Miromatrix Medical during the 1st quarter worth approximately $105,000. Institutional investors own 20.40% of the company’s stock.
About Miromatrix Medical
Miromatrix Medical Inc, a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells.
Further Reading
Receive News & Ratings for Miromatrix Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Miromatrix Medical and related companies with MarketBeat.com’s FREE daily email newsletter.
Read More: Miromatrix Medical (NASDAQ:MIRO) Stock Price Up 0.5%